Alghosoon Haneen, Arafat Amr A, Albabtain Monirah A, Alsubaie Faisal F, Alangari Abdulaziz S
Research Department, Prince Sultan Cardiac Center, Riyadh 12233, Saudi Arabia.
Department of Epidemiology and Biostatistics, College of Public Health and Health Informatics, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia.
J Cardiovasc Dev Dis. 2023 Jul 16;10(7):302. doi: 10.3390/jcdd10070302.
New-onset postoperative atrial fibrillation (PoAF) is one of the most frequent yet serious complications following cardiac surgery. Long-term consequences have not been thoroughly investigated, and studies have included different cardiac operations. The objectives were to report the incidence and short- and long-term outcomes in patients with PoAF after mitral valve surgery.
This is a retrospective cohort study of 1401 patients who underwent mitral valve surgery from 2009 to 2020. Patients were grouped according to the occurrence of PoAF ( = 236) and the nonoccurrence of PoAF ( = 1165). Long-term outcomes included mortality, heart failure rehospitalization, stroke, and mitral valve reinterventions.
The overall incidence of PoAF was 16.8%. PoAF was associated with higher rates of operative mortality (8.9% vs. 3.3%, < 0.001), stroke (6.9% vs. 1.5%, < 0.001), and dialysis (13.6% vs. 3.5%, < 0.001). ICU and hospital stays were significantly longer in patients with PoAF ( < 0.001 for both). PoAF was significantly associated with an increased risk of mortality [HR: 1.613 (95% CI: 1.048-2.483); = 0.03], heart failure rehospitalization [HR: 2.156 (95% CI: 1.276-3.642); = 0.004], and stroke [HR: 2.722 (95% CI: 1.321-5.607); = 0.007]. However, PoAF was not associated with increased mitral valve reinterventions [HR: 0.938 (95% CI: 0.422-2.087); = 0.875].
Atrial fibrillation after mitral valve surgery is a common complication, with an increased risk of operative mortality. PoAF was associated with lower long-term survival, increased heart failure rehospitalization, and stroke risk. Future studies are needed to evaluate strategies that can be implemented to improve the outcomes of these patients.
术后新发房颤(PoAF)是心脏手术后最常见且严重的并发症之一。其长期后果尚未得到充分研究,且各项研究纳入了不同的心脏手术。本研究目的是报告二尖瓣手术后发生PoAF患者的发病率及短期和长期预后情况。
这是一项对2009年至2020年期间接受二尖瓣手术的1401例患者的回顾性队列研究。患者根据是否发生PoAF(n = 236)分为两组,未发生PoAF的患者为另一组(n = 1165)。长期预后指标包括死亡率、因心力衰竭再次住院、中风以及二尖瓣再次干预。
PoAF的总体发生率为16.8%。PoAF与较高的手术死亡率(8.9% 对3.3%,P < 0.001)、中风发生率(6.9% 对1.5%,P < 0.001)以及透析率(13.6% 对3.5%,P < 0.001)相关。PoAF患者的重症监护病房(ICU)和住院时间显著更长(两者P均 < 0.001)。PoAF与死亡风险增加显著相关[风险比(HR):1.613(95%置信区间:1.048 - 2.483);P = 0.03]、因心力衰竭再次住院风险增加[HR:2.156(95%置信区间:1.276 - 3.642);P = 0.004]以及中风风险增加[HR:2.722(95%置信区间:1.321 - 5.607);P = 0.007]。然而,PoAF与二尖瓣再次干预增加无关[HR:0.938(95%置信区间:0.422 - 2.087);P = 0.875]。
二尖瓣手术后房颤是一种常见并发症,手术死亡率风险增加。PoAF与较低的长期生存率、因心力衰竭再次住院增加以及中风风险增加相关。未来需要开展研究以评估可实施的策略,从而改善这些患者的预后。